Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Clinical Chemistry Analyzers Detect Drugs of Abuse

By LabMedica International staff writers
Posted on 09 Jul 2009
Clinical chemistry analyzers use new reagents to detect 10 drugs of abuse (DoA) in human urine. More...


DoA tested for include cannabinoids (THC), cocaine metabolite, EDDP, ecstasy (MDMA), methadone, opiates, amphetamines, barbiturates, benzodiazepines, and ethanol.

Randox (Crumlin, UK) have launched DoA reagents for use on its RX series of clinical chemistry analyzers, RX Daytona and RX Imola. The analyzers and reagents provide systems that offer time, labor, and cost savings.

The RX Daytona is a compact, fully automated, random access analyzer with a throughput of 180 photometric tests and 270 independent security evaluators (ISE) tests per hour. The RX Imola is a fully automated random access benchtop analyzer capable of performing 400 photometric tests per hour and 240 ISE tests per hour. The analyzers are suitable for all types and sizes of laboratories.

Randox DoA assays are precise, stable, and accurate. The new assays are suited for use in police/crime laboratories, hospital laboratories, prison laboratories, as well as private screening laboratories. A comprehensive range of quality control sera is available.

Randox is an international diagnostics company that develops, manufactures, and markets clinical diagnostic products worldwide. Core products include clinical chemistry analyzers and reagents; biochip array technology; quality controls; and recombinant proteins and antibodies.

Related Links:

Randox


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DROP-AD in-house collection and extraction protocol and testing procedures (Huber, H., Montoliu-Gaya, L., Brum, W.S. et al.; Nat Med (20256); doi.org/10.1038/s41591-025-04080-0)

At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers

Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.